Tuesday, September 8, 2020

Probiotics and Prebiotics

Probiotics and Prebiotics

Probiotic means “for life” (Latin and Greek) and probiotic bacteria influence general health and well-being through their association with the gastrointestinal tract (GIT) and its normal microbiota. The concept of probiotics was first coined by Elie Metchnikoff.  He proposed that a normal, healthy gastrointestinal microbiota in humans and animals provided resistance against “putrefactive” intestinal pathogens and he isolated a Lactobacillus culture from a fermented milk which provided health benefits.

Our body are colonized by thousands of microbial species that exist as commensals, largely on mucosal tissues of the nose, mouth, GIT, and vagina.  Some of the most widely used probiotic species are part of the natural commensal microbiota. They have proteins helping them for metabolic activities for sugar harvesting and adherence to host.

1014 bacterial cells are found in the human body, 10-fold more cells than the 1013 mammalian cells comprising the human body itself.  Most of these bacterial cells reside in the GIT.  The composition of the GIT microbiota is complex, dynamic, and specific to each host and change markedly with diet, age, and lifestyle. They are responsible for many important properties that affect the metabolism of food and drugs, the renewal of gut epithelial cells, immune system development, heart size, and general behavioral characteristics. The impact of the microbiota on the host can depend on many factors such as diet, age, exposure to exogenous microorganisms, the genetic makeup of the host, and physiological conditions of the host tissues.

The digestive tract is composed of four major categories

·         Autochthonous microbiota: populations of microbes that have permanently colonized the host and are present in large numbers

·         Normal microbiota: microorganisms that are frequently present but can vary in number and be sporadically absent

·         Pathogens: microorganisms that are periodically acquired but can persist and cause infection and disease

·         Allochthonous microbiota: microbes of another origin that are present temporarily (most probiotic cultures are allochthonous)

Only a small proportion of the GIT microflora is culturable. Molecular biology techniques are used for their studies. Each person has a persistent flora that can be recovered repeatedly over extended periods. Severe disturbances to the GIT, such as antibiotic therapy, enteric infections, or dietary stress, can temporarily disrupt the autochthonous and normal microbiota. However, these populations quickly recover.

Lactobacillus and Bifidobacterium species are natural residents of the GIT and are beneficial to the health of their hosts and pose no risk to the host. Some species of Bacillus and Escherichia are also proposed as probiotics, but the two major species around which the probiotic concept has evolved are Lactobacillus and Bifidobacterium.

Probiotics is a substance produced by one microorganism that stimulates the growth of another microorganism. It is a live microbial supplement which improves the host intestinal balance and is beneficial to the host. There are many types of probiotic cultures (mono- and mixed strain cultures, multiple probiotic species), applications (gastrointestinal versus topical), and mechanisms of probiotic activity (live cells, dead cells, and cellular components). According to WHO they are “live microorganisms which when administered in adequate amounts confer a health benefit on the host”.

Abiotics are probiotic strains that have been inactivated by lysis, heat, or UV irradiation and have some effectiveness in downregulating inflammatory response in intestinal epithelial cells.

The mechanisms through which probiotics exert their beneficial effects are

1.      Interaction with the immune system. Some probiotics can alter cytokine production by exposed macrophages and dendritic cells and can shift the production of cytokines from the inflammation-inducing interleukin- 12 (IL-12) pathway to the anti-inflammatory IL-10 pathway

2.      Strengthening the mucosal barrier. The GIT functions as a semipermeable barrier that allows the selective passage of certain molecules. Dysfunctional barriers are involved with diseases of the GIT such as inflammatory bowel disease. Probiotic strains reinforce and repair this barrier by stimulating the production of protective proteins, such as mucins, by intestinal epithelial cells.

3.      Exclusion of pathogens. Probiotic strains can inhibit the adherence of bacterial and viral pathogens and prevent infection by them.

Probiotics are used for Animal Nutrition, for Human Health and as Therapeutics for treatment of diseases, including the treatment of diarrheal conditions, inflammatory bowel disease, allergies, and infections of the upper respiratory tract.

 

Prebiotics

Prebiotics are ingredients that selectively promote the growth of the existing beneficial microbiota. Growth factors in human breast milk, which stimulate the growth of Bifidobacterium is an example.

Prebiotic is a nondigestible food ingredient that beneficially affects the host by selectively stimulating the growth and/or activity of one or a limited number of bacteria in the colon and Synbiotic is a combination of a prebiotic ingredient with a probiotic culture.

Food ingredients classified as prebiotics exhibit the following characteristics:

·         Limited hydrolysis and absorption in the upper GIT

·         Selective growth stimulation of beneficial bacteria in the colon

·         Potential to repress pathogens and limit virulence (by attenuation of virulence, immunostimulation, and stimulation of a beneficial flora)

The best-known prebiotics are fructo-oligosaccharides derived from food sources. The largest natural source is inulin from the chicory root which is also found in edible plants like onions, asparagus, bananas, wheat, etc.

Examples of other prebiotic factors are Oligosaccharides, Fructans, Human milk, Lactitol, Synthetic derivative of lactose, etc

 

References

Food Microbiology: Fundamentals and Frontiers, 4th  Edition, Michael P. Doyle, Robert L. Buchanan, ASM Press, Washington, DC 20036


No comments:

Post a Comment